Update on the Neuropathological Diagnosis of Frontotemporal Dementias

J. Trojanowski, Dennis W. Dickson
{"title":"Update on the Neuropathological Diagnosis of Frontotemporal Dementias","authors":"J. Trojanowski, Dennis W. Dickson","doi":"10.1093/JNEN/60.12.1123","DOIUrl":null,"url":null,"abstract":"Previous criteria for Frontotemporal Dementia have primarily been designed for research purposes (1–5). An international group of experts on clinical and neuropathological aspects of frontotemporal dementia (FTD) recently re-assessed criteria for the diagnosis of FTD at a meeting entitled “The Frontotemporal Dementia and Pick's Disease Criteria Conference” held at the National Institutes of Health in Bethesda, MD on July 7, 2000 (see ref #1 and the roster of meeting participants in the Acknowledgments). Building upon a substantial literature on these disorders, the goal of the conference was to update previous FTD diagnostic criteria, taking into account recent research advances to refine guidelines for the clinical and neuropathological diagnosis of FTD (1). Here we provide a brief overview of the most salient points of the neuropathology recommendations for disorders included among FTDs.\n\nAlthough Pick's disease can be considered the prototype of FTDs, in the last 3 decades it became increasingly clear to several research groups that there were a number of other distinct FTD variants that lacked the lobar atrophy and related neuropathology of Pick's disease (1). This prompted the use of a number of different names to designate these disorders, including FTD, frontal lobe degeneration of the non-Alzheimer-type, frontotemporal lobar degeneration (FTLD), dementia lacking distinct histopathology (DLDH), progressive aphasia and semantic dementia (1). Moreover, since several kindreds with FTD and parkinsonism linked to chromosome 17 were shown to have pathogenic tau gene mutations, the term FTDP-17 was used to refer to this hereditary group of FTDs, while a less well-characterized disorder in other patients with evidence of FTD as well as clinical and pathological findings of motor neuron disease (MND) has been designated FTD with MND, and hereditary forms of this disease have been linked to chromosome 9 (1). Since these and other terms have been used to refer to …","PeriodicalId":14858,"journal":{"name":"JNEN: Journal of Neuropathology & Experimental Neurology","volume":"17 4 1","pages":"1123–1126"},"PeriodicalIF":0.0000,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"84","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNEN: Journal of Neuropathology & Experimental Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/JNEN/60.12.1123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 84

Abstract

Previous criteria for Frontotemporal Dementia have primarily been designed for research purposes (1–5). An international group of experts on clinical and neuropathological aspects of frontotemporal dementia (FTD) recently re-assessed criteria for the diagnosis of FTD at a meeting entitled “The Frontotemporal Dementia and Pick's Disease Criteria Conference” held at the National Institutes of Health in Bethesda, MD on July 7, 2000 (see ref #1 and the roster of meeting participants in the Acknowledgments). Building upon a substantial literature on these disorders, the goal of the conference was to update previous FTD diagnostic criteria, taking into account recent research advances to refine guidelines for the clinical and neuropathological diagnosis of FTD (1). Here we provide a brief overview of the most salient points of the neuropathology recommendations for disorders included among FTDs. Although Pick's disease can be considered the prototype of FTDs, in the last 3 decades it became increasingly clear to several research groups that there were a number of other distinct FTD variants that lacked the lobar atrophy and related neuropathology of Pick's disease (1). This prompted the use of a number of different names to designate these disorders, including FTD, frontal lobe degeneration of the non-Alzheimer-type, frontotemporal lobar degeneration (FTLD), dementia lacking distinct histopathology (DLDH), progressive aphasia and semantic dementia (1). Moreover, since several kindreds with FTD and parkinsonism linked to chromosome 17 were shown to have pathogenic tau gene mutations, the term FTDP-17 was used to refer to this hereditary group of FTDs, while a less well-characterized disorder in other patients with evidence of FTD as well as clinical and pathological findings of motor neuron disease (MND) has been designated FTD with MND, and hereditary forms of this disease have been linked to chromosome 9 (1). Since these and other terms have been used to refer to …
额颞叶痴呆的神经病理诊断进展
以前的额颞叶痴呆标准主要是为了研究目的而设计的(1-5)。额颞叶痴呆(FTD)的临床和神经病理学方面的国际专家小组最近在2000年7月7日在马里兰州贝塞斯达的国家卫生研究院举行的题为“额颞叶痴呆和皮克病标准会议”的会议上重新评估了FTD的诊断标准(见参考文献1和致谢部分的会议参与者名单)。在大量关于这些疾病的文献的基础上,会议的目标是更新以前的FTD诊断标准,考虑到最近的研究进展,以完善FTD的临床和神经病理学诊断指南(1)。在这里,我们简要概述了FTD中包括的疾病的神经病理学建议的最突出要点。虽然皮克病可以被认为是FTDs的原型,但在过去的30年里,几个研究小组越来越清楚地发现,还有许多其他不同的FTD变体,它们缺乏皮克病的脑叶萎缩和相关的神经病理学(1)。这促使人们使用许多不同的名称来指定这些疾病,包括FTD、非阿尔茨海默病型额叶变性、额颞叶变性(FTLD)、此外,由于与17号染色体相关的几种FTD和帕金森病患者被证明具有致病性tau基因突变,因此FTDP-17一词被用于指代这一遗传性FTDs组,而在其他有FTD证据以及临床和病理表现为运动神经元病(MND)的患者中,一种特征不太明确的疾病被称为FTD伴MND。这种疾病的遗传形式与9号染色体有关(1)。由于这些和其他术语被用来指…
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信